The Trinity Love Hoblit Foundation, a non-profit 501 (c)(3), established in 2016 is headquartered in Amelia Island, Florida. Its purpose is to support and fund neurological research, training, and treatment for brain aneurysms, strokes, and other cerebrovascular conditions; and to raise awareness and educate the public about the causes, identification, diagnoses, prevention, and treatment of brain aneurysms, strokes, and other cerebrovascular conditions.
85% of the net proceeds received by the foundation go directly to the programs we support and 15% go toward fundraising and admin. If you are interested in volunteering, please give us a call.
trinity's story
At age nine, Trinity was diagnosed with multiple brain aneurysms. Over the years, she went through many brain surgeries. In 2015, Trinity was scheduled for open brain surgery for an aneurysm clipping, but two days prior to her pre-op her aneurysm ruptured. She passed away on June 30th, 2015 at age fourteen.
Trinity was an advocate of organ donation, and with her family’s support, she gave life to three donor recipients after her death. Her heart was gifted to a five-year-old boy who had been awaiting a heart for over a year. Her liver was gifted to a six-month-old baby boy, and one of her kidneys was gifted to a 29-year-old woman. These three recipients are alive today as a result of Trinity and her family’s support for organ donation.
Trinity's legacy and kind spirit continue to impact so many lives today. The Trinity Love Hoblit Foundation, a 501(c)(3) non-profit organization, was established in honor of Trinity.
About the Endowment
The Trinity Love Hoblit Foundation Endowment was established to support neurological research, training, and treatment for brain aneurysms, strokes, and other cerebrovascular conditions at Wolfson’s Children’s Hospital and Baptist Neurological Institute. Endowments are an ideal way to establish a legacy that helps future generations. Due to the uncertain financial landscape surrounding health care, endowment gifts have never been more important than they are today.
Ricardo A. Hanel, MD, PhD
Director, Baptist Neurological Institute
Endowed Chair of Stroke and Cerebrovascular Surgery Baptist Health System
Ricardo A. Hanel, MD, PhD, neurovascular surgeon with Lyerly Neurosurgery and Baptist Health, is Endowed Chair of Stroke and Cerebrovascular Surgery & director of Baptist Neurological Institute at Baptist Medical Center Jacksonville. He is internationally known for his skills in treating brain aneurysms, acute stroke and cerebrovascular conditions with ground breaking, minimally invasive techniques performed from inside the blood vessel.
He specializes in endovascular neurosurgery, brain aneurysms, brain & spinal arterial venous malformations, brain & spinal arterial venous fistulas, acute stroke intervention, cerebrovascular disease and skull base neurosurgery.
Philipp R. Aldana,
M.D., FAANS, FAAP
Chief, Division of Pediatric Neurosurgy
Philipp R. Aldana, M.D., FAANS, FAAP is pediatric neurosurgeon who has dedicated his career to improving the lives of children with neurosurgical disease. He is a member of the faculty of the University of Florida College of Medicine Jacksonville, where he is an Associate Professor of Neurosurgery and Pediatrics and Chief of the Division of Pediatric Neurosurgery. He holds the H.E. James Endowed Chair in Pediatric Neurosurgery at Wolfson Children’s Hospital and serves as the Co-director of the Stys Neuroscience Institute.
Dr. Aldana started his medical studies at the University of the Philippines and obtained his medical degree from St. Louis University Medical School. He did his fellowships in neurological surgery at the University of Miami and University of Utah/Primary Children’s Medical Center in Salt Lake City, Utah.
Ajay K. Wakhloo, MD, PhD
Interventional Neuroradiology
Lahey Hospital and Medical Center
Dr. Wakhloo is an internationally renowned tenured Professor of Radiology, Neurology and Neurosurgery and the Director, Division Neuro Imaging and Intervention in the Dept. of Radiology, University of Massachusetts Medical School.
He pioneered the field of flow diversion, the newest technology for the minimally invasive treatment of brain aneurysm. He has over 500 publications, presentations and abstracts, including 2 books on stroke treatment, and more than 250 peer reviewed articles and book chapters. He has been the recipient of numerous scientific awards and honors, among others Whitaker Bioengineering Research Foundation Award, German Society of Neuroradiology and Society of Vascular Interventional Neurology Innovation Award. He was named a Fellow of the American Heart Association and the Stroke Council in 2009. He holds several US patents for neurovascular devices.
He has been the central figure in the commercial development of this technology, which is undergoing a U.S. Food and Drug Administration premarket approval clinical trial. He was also the first to introduce and publish the concept of using a stent to remove an embolus for the treatment of stroke which is currently the standard endovascular treatment for acute ischemic stroke. He has been a founder and has served as CEO and CMO of various medical device companies.
Dr. Wakhloo has served on numerous Editorial Boards and is a reviewer for more than 15 Medical Journals, is currently a consulting editor for Stroke and has served in wide capacity on several national and international professional societies. He is a member of the Medical Advisory Boards for several Pharmaceutical and Device companies. He has consistently held positions of university and departmental services. He has, throughout his career, been dedicated to teaching and mentoring faculty, fellows and residents from various disciplines as well as supervising doctoral students and serving as a research adviser to individuals throughout their research careers.
Dr. Wakhloo is a member of key societies in the field of cerebrovascular disorders (AANS, CNS, IEEE, ASNR, SNIS, ASSR, AHA, RSNA, ARRS) and he is a Fellow of the International Academy of Clinical and Applied Thrombosis/Homeostasis. His primary areas of focus include acute stroke therapy, isolation of intracranial aneurysms and arteriovenous malformations.